Single Ascending Dose Study of M529101 in Healthy Subjects
Phase 1
- Conditions
- Oral and Pharyngeal mucositis associated with cancer treatment
- Registration Number
- JPRN-jRCT2031210455
- Lead Sponsor
- ishiura Tomoyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 32
Inclusion Criteria
(1)Healthy Non-smoking men who are 20 to 34 years of age at the time of informed consent.
(2)BMI of 18.5 to 24.9 kg/m2
Exclusion Criteria
(1)Individuals with a history of hepatic, renal, cardiac and other cardiovascular, gastrointestinal, hematologic, or other diseases considered inappropriate for paticipation in the clinical study
(2)Individuals with a dental, oral or pharyngeal mucosa disease (including wounds)
(3)Individuals with subjective symptom of dysgeusia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method